Literature DB >> 11274306

Risk of dementia in Parkinson's disease: a community-based, prospective study.

D Aarsland1, K Andersen, J P Larsen, A Lolk, H Nielsen, P Kragh-Sørensen.   

Abstract

OBJECTIVE: To calculate the incidence of and determine possible risk factors for dementia in PD.
BACKGROUND: Dementia has important clinical consequences for patients with PD and their caregivers, but the incidence is unknown.
METHODS: A population-based cohort of nondemented patients with PD (n = 171) from the county of Rogaland, Norway, was assessed at baseline and 4.2 years later with a comprehensive evaluation of motor, cognitive, and neuropsychiatric symptoms. The diagnosis of dementia was made according to the Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised (DSM-III-R) criteria, based on interview of the patient and a caregiver, cognitive rating scales, and neuropsychologic tests. A representative sample of 3,062 nondemented elderly subjects without PD served as control group.
RESULTS: Forty-three patients with PD were demented at follow-up evaluation, equivalent to an incidence rate of 95.3 per 1,000 person-years (95% CI, 68.2 to 122.0). The risk for the development of dementia in patients with PD relative to the control subjects after adjusting for age, sex, and education was 5.9 (95% CI, 3.9 to 9.1). Predictive factors at baseline for dementia in PD in addition to age were Hoehn &amp; Yahr score >2 (OR, 3.4; 95% CI, 1.3 to 8.6) and Mini-Mental State Examination score < 29 (OR, 3.3; 95% CI, 1.3 to 8.2).
CONCLUSIONS: Patients with PD have an almost sixfold increased risk for becoming demented compared with subjects without PD.

Entities:  

Mesh:

Year:  2001        PMID: 11274306     DOI: 10.1212/wnl.56.6.730

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  152 in total

Review 1.  Neuropsychiatric non-motor aspects of Parkinson's disease.

Authors:  B R Thanvi; S K Munshi; N Vijaykumar; T C N Lo
Journal:  Postgrad Med J       Date:  2003-10       Impact factor: 2.401

Review 2.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

3.  Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease.

Authors:  Thuy C Vu; John G Nutt; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

4.  Gray matter atrophy in patients with Parkinson's disease and those with mild cognitive impairment: a voxel-based morphometry study.

Authors:  Jing Zhang; Yun-Ting Zhang; Wei-Dong Hu; Li Li; Guang-Yao Liu; Yu-Ping Bai
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 5.  Mild cognitive impairment in Parkinson's disease.

Authors:  Saul Martinez-Horta; Jaime Kulisevsky
Journal:  J Neural Transm (Vienna)       Date:  2019-04-08       Impact factor: 3.575

6.  Past appendectomy may be related to early cognitive dysfunction in Parkinson's disease.

Authors:  Alexandra R Gonçalves; Alexandre Mendes; Nuno Vila-Chã; Joana Damásio; Joana Fernandes; Sara M Cavaco
Journal:  Neurol Sci       Date:  2020-06-11       Impact factor: 3.307

7.  Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.

Authors:  Sean J Colloby; E David Williams; David J Burn; Jim J Lloyd; Ian G McKeith; John T O'Brien
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06-02       Impact factor: 9.236

8.  Melatonin attenuates hLRRK2-induced long-term memory deficit in a Drosophila model of Parkinson's disease.

Authors:  Dongzhi Ran; Baogang Xie; Zongjie Gan; Xicui Sun; Huaiyu Gu; Junqing Yang
Journal:  Biomed Rep       Date:  2018-07-05

9.  Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease.

Authors:  Eliseu Felippe dos Santos; Estela Natacha Brandt Busanello; Anelise Miglioranza; Angela Zanatta; Alethea Gatto Barchak; Carmen Regla Vargas; Jonas Saute; Charles Rosa; Maria Júlia Carrion; Daiane Camargo; André Dalbem; Jaderson Costa da Costa; Sandro René Pinto de Sousa Miguel; Carlos Roberto de Mello Rieder; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2009-03-18       Impact factor: 3.584

10.  Cognitive impairments in progression of Parkinson's disease.

Authors:  D A Stepkina; V V Zakharov; N N Yakhno
Journal:  Neurosci Behav Physiol       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.